Anand SS - Search Results

1

Rivaroxaban and Aspirin in Patients With Symptomatic Lower Extremity Peripheral Artery Disease: A Subanalysis of the COMPASS Randomized Clinical Trial.

Kaplovitch E, Eikelboom JW, Dyal L, Aboyans V, Abola MT, Verhamme P, Avezum A, Fox KAA, Berkowitz SD, Bangdiwala SI, Yusuf S, Anand SS. Kaplovitch E, et al. Among authors: anand ss. JAMA Cardiol. 2021 Jan 1;6(1):21-29. doi: 10.1001/jamacardio.2020.4390. JAMA Cardiol. 2021. PMID: 32997098 Free PMC article. Clinical Trial.

2

Pharmacological treatment for myocardial infarction Part 2: Implications of clinical trials of other adjunctive therapies.

Avezum A Jr, Pais P, Flather MD, Anand S, Yusuf S. Avezum A Jr, et al. Indian Heart J. 1995 Mar-Apr;47(2):95-105. Indian Heart J. 1995. PMID: 7590849 Review. No abstract available.

3

Cost of prevention. The case of lipid lowering.

Yusuf S, Anand S. Yusuf S, et al. Circulation. 1996 May 15;93(10):1774-6. doi: 10.1161/01.cir.93.10.1774. Circulation. 1996. PMID: 8635252 No abstract available.

4

Treatment for acute myocardial infarction. Overview of randomized clinical trials.

Yusuf S, Anand S, Avezum A Jr, Flather M, Coutinho M. Yusuf S, et al. Eur Heart J. 1996 Dec;17 Suppl F:16-29. doi: 10.1093/eurheartj/17.suppl_f.16. Eur Heart J. 1996. PMID: 8960444 Review.

5

Classifying ethnicity utilizing the Canadian Mortality Data Base.

Sheth T, Nargundkar M, Chagani K, Anand S, Nair C, Yusuf S. Sheth T, et al. Ethn Health. 1997 Nov;2(4):287-95. doi: 10.1080/13557858.1997.9961837. Ethn Health. 1997. PMID: 9526691

6

Cardiovascular and cancer mortality among Canadians of European, south Asian and Chinese origin from 1979 to 1993: an analysis of 1.2 million deaths.

Sheth T, Nair C, Nargundkar M, Anand S, Yusuf S. Sheth T, et al. CMAJ. 1999 Jul 27;161(2):132-8. CMAJ. 1999. PMID: 10439820 Free PMC article.

7

Cardiovascular diseases in ethnic groups.

Anand S, Yusuf S. Anand S, et al. Can J Cardiol. 1999 Dec;15 Suppl G:47G-50G. Can J Cardiol. 1999. PMID: 10692658 No abstract available.

8

The impending global epidemic of cardiovascular diseases.

Ounpuu S, Anand S, Yusuf S. Ounpuu S, et al. Eur Heart J. 2000 Jun;21(11):880-3. doi: 10.1053/euhj.1999.1880. Eur Heart J. 2000. PMID: 10806010 No abstract available.

9

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.

Yusuf S, Reddy S, Ounpuu S, Anand S. Yusuf S, et al. Circulation. 2001 Nov 27;104(22):2746-53. doi: 10.1161/hc4601.099487. Circulation. 2001. PMID: 11723030 Review.

10

Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

Yusuf S, Reddy S, Ounpuu S, Anand S. Yusuf S, et al. Circulation. 2001 Dec 4;104(23):2855-64. doi: 10.1161/hc4701.099488. Circulation. 2001. PMID: 11733407

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

469 results

Search Page